We identified GCLC, ABCA7, ITGA7, GGH, and GFPT1 as potential therapeutic targets, based on evidence indicating shared genetic influences between their expression quantitative trait loci (eQTLs) and the risk of PD. This evidence concerns the gene GFPT1 and Parkinson disease.